Relationship and significance between HPV infection in Uyghur women cervical lesions and LMP2/7 gene promoter methylation

Chinese Journal of Microbiology and Immunology (China)

Volumn 32, Issue 3, 2012, Pages 205-211

  Hasim, Ayshamgul ^a   Tuerxun, Hatila ^a   Kuerban, Gulinaer ^a   Ma, Jun Qi ^b   Abudla, Abulizi ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Cervical cancer of Uyghur women; DNA methylation; Human papillomavirus; Low molecular weight protein

Indexed keywords

CELL DNA; LOW MOLECULAR WEIGHT PROTEIN 2; LOW MOLECULAR WEIGHT PROTEIN 7; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CPG ISLAND; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM;

EID: 84861927460     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0254-5101.2012.03.003     Document Type: Article

References (15)

1. 2010, 38(12): 764-765.
2. 2010, 45(9): 709-711.
3. Shen Y Q, Zhang J Q, Xia M, et al. Low-molecular-weight protein (LMP) 2/LMP7 abnormality underlies the downregulation of human leukocyte antigen class I antigen in a hepatocellular carcinoma cell line. J Gastroenterol Hepatol, 2007, 22(7): 1155-1161.
4. Seliger B, Ritz U, Ferrone S. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer, 2006, 118(1): 129-138.
5. Aptsiauri N, Cabrera T, Mendez R, et al. Role of altered expression of HLA class I molecules in cancer progression. Adv Exp Med Biol, 2007, 601: 123-131.
6. Bandoh N, Ogino T, Katayama A, et al. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis. Oncol Rep, 2010, 23(4): 933-939.
7. Ehrich M, Nelson M R, Stanssens P, et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. PNAS, 2005, 102 (44): 15785-15790.
8. Huang Y W, Luo J, Weng Y I, et al. Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas. Gynecol Oncol, 2010, 117(2): 239-247.
9. Herman J G, Baylin S B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med, 2003, 349(21): 2042-2054.
10. Paulin R, Grigg G W, Davey M W, et al. Urea improves efficiency of bisulphate-mediated sequencing of 5'-methylcytosine in genomic DNA. Nucleic Acids Res, 1998, 26(21): 5009-5010.
11. Mehta A M, Jordanova E S, Kenter G G, et al. Association of antigen processing machinery and HLA class I defects with clinico-pathological outcome in cervical carcinoma. Cancer Immunol Immunother, 2008, 57(2): 197-206.
12. Manning J, Indrova M, Lubyova B, et al. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours. Immunology, 2007, 123(2): 218-227.
13. 2010, 39(10): 703-704.
14. Kuzmin I, Liu L, Dammann R, et al. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res, 2003, 63 (8): 1888-1893.
15. 2009, 43(7). 571-575.